Silexion Therapeutics Corp (NASDAQ:SLXN) currently has a daily average trading volume of 5.80M but it saw 5944263 shares traded in last market. With a market cap of 4.62M USD, the company’s current market price of $0.32 came falling about -3.81 while comparing to the previous closing price of $0.33. In past 52 weeks, the stock remained buoying in the range of price level as high as $13.56 and as low as $0.21. In the recent trading on the day, stock has struck highest price mark of $0.2401 while lowest mark touched by it was $0.33.
Taking a look at 20-day trading activity of Silexion Therapeutics Corp (SLXN) gives us an average price of $0.2678, while its current price level is -97.64% below from 52-week high level whereas it is 54.78% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.4286. A closer look into the stock’s movement over the week reveals that its volatility is standing at 25.71% during that period while stretching the period over a month that decreases to 15.19%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 42.90 which implies that the stock is in neutral territory.
Over the week, SLXN’s stock price is moving 43.23% up while it is 4.74% when we observe its performance for the past one month. Year-to-date it is -97.05% down and over the past year, the stock is showing a downside performance of -96.79%.
The company is expected to be releasing its next quarterly report in December, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Silexion Therapeutics Corp’s total number of outstanding shares is 3.87M with 33.99% of that held by the insiders while 8.50% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -20.64% and return on equity (ROE) at -3.78%. Stock’s beta reads -0.06. Stock has a price to book (P/B) ratio of 0.49. Its return on asset (ROA) is -3.13% on average.
